ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 20 filers reported holding ELIEM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,586,733 | -6.1% | 13,150,849 | 0.0% | 0.68% | -2.0% |
| Q2 2023 | $36,822,377 | -3.4% | 13,150,849 | 0.0% | 0.70% | -19.5% |
| Q1 2023 | $38,137,462 | -21.0% | 13,150,849 | 0.0% | 0.86% | -11.8% |
| Q4 2022 | $48,263,616 | +13.6% | 13,150,849 | 0.0% | 0.98% | +8.1% |
| Q3 2022 | $42,477,000 | +7.0% | 13,150,849 | 0.0% | 0.91% | -14.4% |
| Q2 2022 | $39,716,000 | -64.0% | 13,150,849 | 0.0% | 1.06% | -56.0% |
| Q1 2022 | $110,336,000 | -19.8% | 13,150,849 | 0.0% | 2.41% | -0.7% |
| Q4 2021 | $137,558,000 | -41.8% | 13,150,849 | 0.0% | 2.42% | -26.0% |
| Q3 2021 | $236,452,000 | – | 13,150,849 | – | 3.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,658,170 | $4,808,693 | 4.16% |
| RA Capital Management | 13,150,849 | $38,137,462 | 0.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 485,955 | $1,409,270 | 0.58% |
| Atom Investors LP | 78,886 | $228,769 | 0.12% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 673,684 | $1,953,684 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 55,223 | $160,147 | 0.00% |
| Chicago Partners Investment Group LLC | 18,520 | $52,412 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 29,706 | $86 | 0.00% |
| NORTHERN TRUST CORP | 11,247 | $32,616 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |